Stocks-GSK-GlaxoSmithKline plc ADR

GSK GlaxoSmithKline plc ADR

39.13 0.30 (0.77%)
Market ClosedDelayed Prices By NASDAQ, in USD
Trade
Stocks-GSK-GlaxoSmithKline plc ADR
GSK GlaxoSmithKline plc ADR
Trade

Overview

Prev Close 39.13
Day's Range 38.76 - 39.16
52 Week Range 33.62 - 45.85
Average Volume (3M) 4.01M
1-Year Return 6.97%
Beta0.2446
Market Cap 79.81B
P/E Ratio15.62
Revenue39.58B
EPS2.5054
Dividend (Yield) 1.508355 (3.85%)
Sector
Health Technology
Industry
Pharmaceuticals Major
CEO
Emma N. Walmsley
Employees
70,212

FINANCIAL SUMMARY

For the fiscal year ended 31/12/2023: GlaxoSmithKline plc ADR's revenues increased by 4.37% and amounted to 37.70B. Net income increased by 8.85% to 6.60B. Net assets increased by 34.31% to 16.31B and EPS decreased from 9.02 to 2.98.
GSK's Investor Relations
Income StatementBalance SheetCash Flow Statement
Quarterly
Gross Margin
70.99%
Net Profit Margin
15.10%
Operating Margin
23.93%
Return On Investment
13.96%
09/23
12/23
03/24
06/24
Total Revenue
10.31B
9.99B
9.34B
9.95B
Gross Profit
7.45B
7.09B
6.88B
7.32B
Operating Income
2.84B
1.31B
2.51B
2.5B
Net Income
1.94B
493.76M
1.37B
1.65B